These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 4385710)
41. Opsonizing factors in human serum. II. The opsonin and inhibitor of phagocytosis of Staphylococcus aureus. Slopek S; Grzybek-Hryncewicz K; Ladosz J; Kubis-Parusel K Arch Immunol Ther Exp (Warsz); 1967; 15(1):18-25. PubMed ID: 6057642 [No Abstract] [Full Text] [Related]
42. Interview with Frank A. Oski: prevention of pneumococcal infection in children with sickle cell hemoglobinopathies. Oski FA Pediatr Infect Dis; 1983; 2(3):184-6. PubMed ID: 6866783 [No Abstract] [Full Text] [Related]
43. Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins. Smith MR; Shin HS; Wood WB Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1151-6. PubMed ID: 4390986 [TBL] [Abstract][Full Text] [Related]
44. Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. Brady AM; Calix JJ; Yu J; Geno KA; Cutter GR; Nahm MH J Infect Dis; 2014 Oct; 210(7):1155-65. PubMed ID: 24683196 [TBL] [Abstract][Full Text] [Related]
45. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Simell B; Vuorela A; Ekström N; Palmu A; Reunanen A; Meri S; Käyhty H; Väkeväinen M Vaccine; 2011 Feb; 29(10):1929-34. PubMed ID: 21236231 [TBL] [Abstract][Full Text] [Related]
46. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575 [TBL] [Abstract][Full Text] [Related]
47. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. Giebink GS; Foker JE; Kim Y; Schiffman G J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526 [No Abstract] [Full Text] [Related]
48. Pneumococcal infections in children with sickle cell disease: increased incidence, immunological defects, vaccine failure, and prospects for the future. Lembo NJ J Natl Med Assoc; 1981 Jan; 73(1):43-5. PubMed ID: 7463494 [TBL] [Abstract][Full Text] [Related]
50. Host defense against the pneumococcus in T-lymphocyte-deficient, nude mice. Winkelstein JA; Swift AJ Infect Immun; 1975 Nov; 12(5):1222-3. PubMed ID: 334 [TBL] [Abstract][Full Text] [Related]
51. The splenic platelet reservoir in sickle cell anemia. Schwartz AD Blood; 1972 Nov; 40(5):678-83. PubMed ID: 5078926 [No Abstract] [Full Text] [Related]
52. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547 [TBL] [Abstract][Full Text] [Related]
53. Opsonizing factors in human serum. I. Factors inhibiting and stimulating phagocytosis of Shigella sonnei (phase II). Slopek S; Ladosz J; Grzybek-Hryncewicz K; Kubis-Parusel K Arch Immunol Ther Exp (Warsz); 1967; 15(1):10-7. PubMed ID: 4965190 [No Abstract] [Full Text] [Related]
54. [Infection and immunity in sickle cell disease]. Falcão RP; Donadi EA AMB Rev Assoc Med Bras; 1989; 35(2):70-4. PubMed ID: 2695986 [TBL] [Abstract][Full Text] [Related]
55. Reimmunization to pneumococcus in patients with sickle cell disease: do they or don't they respond? Rao SP; Rajkumar K; Schiffman G; Unger C J Pediatr; 1997 Sep; 131(3):498-9. PubMed ID: 9329440 [No Abstract] [Full Text] [Related]
56. C-reactive protein reactivity with complement and effects on phagocytosis. Mold C; Du Clos TW; Nakayama S; Edwards KM; Gewurz H Ann N Y Acad Sci; 1982; 389():251-62. PubMed ID: 7046579 [TBL] [Abstract][Full Text] [Related]
57. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. Bjornson AB; Falletta JM; Verter JI; Buchanan GR; Miller ST; Pegelow CH; Iyer RV; Johnstone HS; DeBaun MR; Wethers DL; Wang WC; Woods GM; Holbrook CT; Becton DL; Kinney TR; Reaman GH; Kalinyak K; Grossman NJ; Vichinsky E; Reid CD J Pediatr; 1996 Dec; 129(6):828-35. PubMed ID: 8969724 [TBL] [Abstract][Full Text] [Related]
58. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19. Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784 [TBL] [Abstract][Full Text] [Related]
59. THE OPSONIZING FACTOR IN RABBIT SERUM. GRZYBEK-HRYNCEWICZ K; KUBIS K; SLOPEK S Arch Immunol Ther Exp (Warsz); 1964; 12():670-5. PubMed ID: 14249827 [No Abstract] [Full Text] [Related]
60. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. Robbins JB; Austrian R; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J; Mäkelä PH; Broome CV; Facklam RR; Tiesjema RH J Infect Dis; 1983 Dec; 148(6):1136-59. PubMed ID: 6361173 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]